The 2024 UNITE4TB Annual Consortium Meeting and Joint Symposium with ERA4TB
Snapshot of the 2024 UNITE4TB-ERA4TB Joint Symposium
Snapshot of the 2024 UNITE4TB Consortium Meeting
Stakeholder perspectives on UNITE4TB
A new dawn in the fight against TB: Start of the UNITE4TB clinical trials
Prof. Martin Boeree, Radboud University Medical Center, explains the UNITE4TB phase 2B/C clinical trial program
Phumeze Tisile, TB survivor, TB Proof / GCTA Board Member, speaks on the importance of involving key local stakeholders in the UNITE4TB clinical trials
Prof. Andreas Diacon, UNITE4TB Phase 2A Clinical Trials Leader at TASK, speaks about the UNITE4TB phase 2B/C clinical trial program
Dr. Ilaria Motta, Clinical Research Fellow, Medical Research Council Clinical Trials Unit at UCL, explains the UNITE4TB-01/PARADIGM4TB Clinical Trial program
Dr. Wandini Lutchmun, LMU University Hospital Munich, speaks about the UNITE4TB phase 2B/C clinical trial program
Impressions of the 2023 UNITE4TB Annual Meeting & Symposium
